CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation

Multiple myeloma (MM) is an incurable plasma cell malignancy, while CAR-T therapy offers a new direction for the treatment of MM. Recently, signaling lymphocytic activation molecule family 3 (CD229), a cell surface immune receptor belonging to the signaling lymphocyte activating molecule family (SLA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zigen, Tang, Xiaozhu, Cao, Yuhao, Yang, Lijin, Jiang, Mingmei, Li, Xinying, Min, Jie, Chen, Bing, Yang, Ye, Gu, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740379/
https://www.ncbi.nlm.nih.gov/pubmed/36445333
http://dx.doi.org/10.18632/aging.204405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740379/
https://www.ncbi.nlm.nih.gov/pubmed/36445333
http://dx.doi.org/10.18632/aging.204405

Ejemplares similares